Compare III & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | III | ORGO |
|---|---|---|
| Founded | 2006 | 1985 |
| Country | United States | United States |
| Employees | 1500 | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.1M | 181.4M |
| IPO Year | 2006 | 2016 |
| Metric | III | ORGO |
|---|---|---|
| Price | $5.74 | $1.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $6.80 | $2.00 |
| AVG Volume (30 Days) | 185.0K | ★ 534.3K |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.25% | N/A |
| EPS Growth | 216.67 | ★ 1600.00 |
| EPS | ★ 0.12 | N/A |
| Revenue | $192,745,000.00 | ★ $564,169,000.00 |
| Revenue This Year | $4.24 | N/A |
| Revenue Next Year | $3.59 | $37.55 |
| P/E Ratio | $45.00 | ★ N/A |
| Revenue Growth | 4.51 | ★ 17.04 |
| 52 Week Low | $3.74 | $1.34 |
| 52 Week High | $6.45 | $7.08 |
| Indicator | III | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 70.83 | 31.90 |
| Support Level | $5.47 | $1.34 |
| Resistance Level | $6.11 | $2.55 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 98.06 | 17.65 |
Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.